Targeting IL-12 for pancreatic cancer immunotherapy: advances in delivery strategies and clinical translation.
New ways to deliver IL-12 directly to pancreatic tumors are advancing toward human trials, offering hope for a disease with few treatment options.
This review examines new strategies for delivering IL-12 to pancreatic tumors to boost anti-cancer immunity. Several delivery platforms are progressing toward clinical trials, addressing a cancer with very limited treatment options.
What the study was
- Study design
- Review
- Population
- Pancreatic cancer patients
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Frontiers in immunology
Why it surfaced
Comprehensive review of IL-12 delivery for pancreatic cancer immunotherapy. Review design limits novelty score.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.